- Report
- August 2024
- 180 Pages
Asia Pacific
From €3692EUR$3,869USD£3,094GBP
- Report
- May 2022
- 365 Pages
Global
From €4580EUR$4,799USD£3,837GBP
- Report
- May 2023
- 375 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- September 2022
- 110 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- May 2022
- 109 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- December 2022
- 78 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- January 2024
- 213 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- April 2020
- 108 Pages
Global
From €1145EUR$1,200USD£960GBP
- Report
- April 2021
- 377 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- September 2021
- 163 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2023
- 343 Pages
Global
From €3340EUR$3,500USD£2,799GBP
€4772EUR$5,000USD£3,998GBP
- Report
- October 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- July 2023
- 280 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2023
- 150 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- May 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3778EUR$3,959USD£3,166GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more